Recent

% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • fudfighter4 fudfighter4 Feb 22, 2013 10:12 AM Flag

    Jesse - beware the "share price says it all" trap

    A double from here would appear to be a really meaningful gain. But doesn't that rather assume that the current share price is a meaningful reflection of the potential?

    I think you've been expertly played over the last few years - and that you're not the first investor to be brainwashed by that strategy -

    Date ----------- Open -- High --- Low --- Close --- Volume

    12/23/2009 - 30.85 - 31.40 - 30.55 - 30.75 - 4,746,144
    12/16/2009 - 28.30 - 28.66 - 27.96 - 28.33 - 2,796,200
    12/09/2009 - 27.51 - 27.69 - 26.76 - 27.11 - 3,555,438
    12/02/2009 - 26.83 - 27.56 - 26.78 - 27.46 - 3,564,268

    11/25/2009 - 28.08 - 28.20 - 27.47 - 27.96 - 2,669,918
    11/18/2009 - 28.50 - 28.70 - 27.77 - 27.84 - 4,661,150
    11/11/2009 - 28.80 - 29.48 - 28.24 - 28.51 - 4,908,632
    11/04/2009 - 27.61 - 28.19 - 26.24 - 26.48 - 12,487,950

    10/28/2009 - 19.30 - 19.37 - 17.83 - 18.01 - 8,588,417
    10/21/2009 - 19.83 - 20.40 - 18.94 - 19.08 - 7,083,437
    10/14/2009 - 19.03 - 19.22 - 18.82 - 19.16 - 7,077,614
    10/07/2009 - 19.45 - 19.65 - 18.64 - 18.96 - 4,982,780

    09/30/2009 - 19.11 - 19.26 - 18.51 - 18.82 - 5,144,892
    09/23/2009 - 19.50 - 19.54 - 18.80 - 18.87 - 4,692,131
    09/16/2009 - 20.04 - 20.30 - 19.77 - 19.90 - 4,546,353
    09/09/2009 - 19.49 - 19.75 - 19.26 - 19.61 - 5,215,776
    09/02/2009 - 18.47 - 18.56 - 17.36 - 17.46 - 10,211,830

    08/26/2009 - 22.00 - 22.78 - 19.42 - 20.50 - 39,614,900
    08/19/2009 - 15.25 - 15.95 - 15.25 - 15.86 - 5,616,838
    08/12/2009 - 15.85 - 16.50 - 15.76 - 16.21 - 8,721,898
    08/05/2009 - 15.16 - 15.18 - 14.58 - 14.90 - 6,429,720

    07/29/2009 - 14.32 - 15.45 - 14.15 - 14.71 - 29,962,190
    07/22/2009 - 14.50 - 14.83 - 13.35 - 14.05 - 33,920,750

    "ROCKVILLE, Maryland, and LONDON, UK – July 20, 2009 – Human Genome Sciences, Inc. (Nasdaq: HGSI) and GlaxoSmithKline PLC (GSK) today announced that BENLYSTA™ (belimumab, formerly LymphoStat-B®) met the primary endpoint in BLISS-52, the first of two pivotal Phase 3 trials in patients with serologically active systemic lupus erythematosus (SLE)."

    07/15/2009 - 2.53 - 2.85 - 2.53 - 2.75 - 7,890,613
    07/08/2009 - 2.65 - 2.67 - 2.25 - 2.39 - 7,129,992
    07/01/2009 - 3.05 - 3.05 - 2.87 - 2.92 - 4,859,325

    06/24/2009 - 2.50 - 2.87 - 2.50 - 2.70 - 6,776,820
    06/17/2009 - 2.54 - 2.54 - 2.23 - 2.37 - 4,596,816
    06/10/2009 - 2.81 - 2.85 - 2.65 - 2.71 - 3,244,967
    06/03/2009 - 2.63 - 3.14 - 2.53 - 3.03 - 10,264,590

    05/27/2009 - 2.00 - 2.08 - 1.96 - 2.03 - 2,288,427
    05/20/2009 - 2.05 - 2.08 - 1.98 - 2.00 - 2,009,725
    05/13/2009 - 1.91 - 1.94 - 1.67 - 1.88 - 4,113,200
    05/06/2009 - 2.01 - 2.32 - 1.91 - 2.13 - 5,488,839

    04/29/2009 - 1.35 - 1.42 - 1.30 - 1.39 - 3,586,157
    04/22/2009 - 1.22 - 1.30 - 1.21 - 1.23 - 1,841,754
    04/15/2009 - 1.10 - 1.48 - 1.07 - 1.41 - 7,928,979
    04/08/2009 - 0.83 - 0.84 - 0.81 - 0.83 - 810,977
    04/01/2009 - 0.85 - 0.89 - 0.80 - 0.85 - 1,033,640

    03/25/2009 - 0.86 - 0.90 - 0.84 - 0.86 - 2,630,082
    03/18/2009 - 0.77 - 0.94 - 0.74 - 0.90 - 3,739,392
    03/11/2009 - 0.57 - 0.57 - 0.45 - 0.48 - 7,698,879

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
INSM
21.09+0.59(+2.88%)Mar 30 4:00 PMEDT